The global Oncology/Cancer Drugs market generated USD 146.72 billion revenue in 2022 and is projected to grow at a CAGR of 7.83% from 2023 to 2032. The market is expected to reach USD 311.81 billion by 2032. The expansion of the market is propelled by a rise in the prevalence of cancer diseases and an increase in the incidence of different cancer diseases. The growing demand for advanced therapies, such as targeted and biological drug therapies, and a significant increase in the global geriatric population further contribute to this growth. Additionally, the heightened awareness of cancer and the early screening of the disease also play pivotal roles in fostering the development of the oncology drugs market.
0 0

Oncology/Cancer Drugs Market 2024: Key Stakeholders, Subcomponent Manufacturers, Industry Associatio

649 × 470 — JPG 68.3 KB

已上传 1 年 前 — 1743 次浏览

The global Oncology/Cancer Drugs market generated USD 146.72 billion revenue in 2022 and is projected to grow at a CAGR of 7.83% from 2023 to 2032. The market is expected to reach USD 311.81 billion by 2032. The expansion of the market is propelled by a rise in the prevalence of cancer diseases and an increase in the incidence of different cancer diseases. The growing demand for advanced therapies, such as targeted and biological drug therapies, and a significant increase in the global geriatric population further contribute to this growth. Additionally, the heightened awareness of cancer and the early screening of the disease also play pivotal roles in fostering the development of the oncology drugs market.

在任何预览上 点击 自定义上传
在任何预览上 触摸 自定义上传
您也可以 浏览您的计算机.
您也可以 浏览您的设备 或 使用照相机。
上传 0 文件 (0% 完成)
队列上传中. 顷刻间便能完成.
上传完毕
图片已经添加到 . 您可以将刚刚上传的图片 创建新的 相册.
图片已经添加到 .
您必须 注册账户 或 登录 才能将此内容保存到您的帐户中。
没有 文件被上传
发生了某些错误，系统无法处理您的请求。
    或 取消取消剩下的
    注意：部分文件无法上传。 了解更多
    检查 错误报告 更多信息.
    重置 取消 取消剩下的